Publikationen

2021

Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
Sartor O, de Bono J, Chi KN, Fizazi K, Herrmann K, Rahbar K, Tagawa ST, Nordquist LT, Vaishampayan N, El-Haddad G, Park CH, Beer TM, Armour A, Pérez-Contreras WJ, DeSilvio M, Kpamegan E, Gericke G, Messmann RA, Morris MJ, Krause BJ; VISION Investigators.
N Engl J Med. 2021 Jun 23.
doi: 10.1056/NEJMoa2107322. Epub ahead of print. PMID: 34161051.

Streamlined Schemes for Dosimetry of 177Lu-Labeled PSMA Targeting Radioligands in Therapy of Prostate Cancer.
Jens Kurth, Martin Heuschkel; Alexander Tonn; Anna Schildt; Oliver W. Hakenberg; Bernd J. Krause; Sarah M. Schwarzenböck
Cancers. 2021; 13(15):3884. https://doi.org/10.3390/cancers13153884

Long-Term Caloric Restriction Attenuates β-Amyloid Neuropathology and Is Accompanied by Autophagy in APPswe/PS1delta9 Mice.
Müller L, Power Guerra N, Stenzel J, Rühlmann C, Lindner T, Krause BJ, Vollmar B, Teipel S, Kuhla A.
Nutrients. 2021; 13(3):985.
https://doi.org/10.3390/nu13030985

Evaluation of [68Ga]Ga-PSMA PET/CT for therapy response assessment of [177Lu]Lu-PSMA radioligand therapy in metastasized castration refractory prostate cancer and correlation with survival.
Kurth, Jens; Kretzschmar, Justus; Aladwan, Hamzeh; Heuschkel, Martin; Gummesson, Anja; Bergner, Carina; Kundt, Günther; Hakenberg, Oliver W.; Krause, Bernd J.; Schwarzenböck, Sarah M.
Nuclear Medicine Communications: May 19, 2021 - Volume Publish Ahead of Print - Issue -
doi: 10.1097/MNM.0000000000001446

PSMA-Radioligandentherapie könnte Nuklearmedizin vor infrastrukturelle Herausforderungen stellen: Ergebnisse einer Basiskalkulation zur Kapazitätsplanung nuklearmedizinischer Betten im deutschen Krankenhaussektor [PSMA radioligand therapy could pose infrastructural challenges for nuclear medicine: results of a basic calculation for the capacity planning of nuclear medicine beds in the German hospital sector].
Zippel C, Giesel FL, Kratochwil C, Eiber M, Rahbar K, Albers P, Maurer T, Krause BJ, Bohnet-Joschko S.
Nuklearmedizin. 2021 Feb 2. German.
doi: 10.1055/a-1351-0030. Epub ahead of print. PMID: 33530110.

Neuroprotective Effects of the FGF21 Analogue LY2405319.
Rühlmann C, Dannehl D, Brodtrück M, Adams AC, Stenzel J, Lindner T, Krause BJ, Vollmar B, Kuhla A.
J Alzheimers Dis. 2021 Jan 30.
doi: 10.3233/JAD-200837. Epub ahead of print. PMID: 33554901.

Regulatorische Anforderungen an Radiopharmaka in Deutschland: die Fachgesellschaft im behördlichen Dialog.
Patt M, Kuwert T, Luster M, Krause BJ, Solbach C.
Nuklearmedizin. 2021 Feb;60(1):55-58. German.
doi: 10.1055/a-1288-6725. Epub 2021 Feb 3. PMID: 33535270

E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET.
Ceci F, Oprea-Lager DE, Emmett L, Adam JA, Bomanji J, Czernin J, Eiber M, Haberkorn U, Hofman MS, Hope TA, Kumar R, Rowe SP, Schwarzenboeck SM, Fanti S, Herrmann K.
Eur J Nucl Med Mol Imaging. 2021 Feb 19.
doi: 10.1007/s00259-021-05245-y. Epub ahead of print. PMID: 33604691.

Der Chemokinrezeptor CXCR4 – seine Entwicklung und Bedeutung in der nuklearmedizinischen Theranostik. [Development and significance of the chemokine receptor CXCR4 for theranostics in nuclearr medicine.]  
Carina Bergner, Anja Gummesson, Markus Joksch, Mohammadreza Kamali Sarvestani, Heike von Helldorff, Constantin Lapa, Bernd J. Krause, Sarah M. Schwarzenböck
Der Nuklearmediziner 2021; 44(02): 160-176
doi: 10.1055/a-1393-7958

Gemeinsame Handlungsempfehlung (S1-Leitlinie) von DGN, OGNMB und SGNM – Radiosynoviorthese – Stand: 9/2019 – AWMF-Registernummer: 031-023 [Joint DGN, OGNMB and SGNM S1 guideline for radiosynoviorthesis].
Gabriel M, Pöppel TD, Freudenberg LS, Farahati J, Krause T, Buchmann I, Panholzer PJ, Mödder G, Becherer A, Kampen WU, Kurth J, Krause BJ, Wissmeyer M, Kresnik E; Weitere Beteiligte; Deutsche Gesellschaft für Rheumatologie e. V. (DGRh); Deutsche Schmerzgesellschaft e. V..
Nuklearmedizin. 2021 Apr;60(2):78-89.
doi: 10.1055/a-1324-4745. PMID: 33836541.

Value of PET imaging for radiation therapy.
Lapa C, Nestle U, Albert NL,  Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC; Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN.
Strahlenther Onkol. 2021 Jul 14.
doi: 10.1007/s00066-021-01812-2 Epub ahead of print. PMID: 34259912

Value of PET imaging for radiation therapy.
Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC; “Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN”.
Nuklearmedizin. 2021 Jul 14. English.
doi: 10.1055/a-1525-7029. Epub ahead of print. PMID: 34261141

E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET.
Ceci F, Oprea-Lager DE, Emmett L, Adam JA, Bomanji J, Czernin J, Eiber M, Haberkorn U, Hofman MS, Hope TA, Kumar R, Rowe SP, Schwarzenboeck SM, Fanti S, Herrmann K. E
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1626-1638.
doi: 10.1007/s00259-021-05245-y. Epub 2021 Feb 19. PMID: 33604691; PMCID: PMC8113168.

Kamingespräch „§ 13 (2b) AMG in der nuklearmedizinischen Therapie” – eine Follow-up-Veranstaltung der NuklearMedizin 2020 – Digital
Fireside chat “§ 13 (2b) AMG in nuclear medicine therapy” – a follow-up event of NuklearMedizin 2020 – Digital
Marianne Patt, Frank Bengel, Markus Essler, Bernd-Joachim Krause, Torsten Kuwert, Kambiz Rahbar, Osama Sabri, Wolfgang Schäfer, Matthias Schreckenberger, Wolfgang A. Weber, Ken Herrmann.
Nuklearmedizin 2021; 60(04): 262-263
doi: 10.1055/a-1489-0375

Interdisziplinärer Expertenkonsensus zu Innovationen der bildgebenden Diagnostik und radionuklidbasierten Therapien des fortgeschrittenen Prostatakarzinoms [Interdisciplinary expert consensus on innovations in imaging diagnostics and radionuclide-based therapies for advanced prostate cancer].
Beyersdorff D, Rahbar K, Essler M, Ganswindt U, Grosu AL, Gschwend JE, Miller K, Scheidhauer K, Schlemmer HP, Wolff JM, Krause BJ.
Urologe A. 2021 Aug 18. German.
doi: 10.1007/s00120-021-01598-2 . Epub ahead of print. PMID: 34406465 .

Impact of the COVID-19 pandemic on nuclear medicine departments in Europe.
Moreira AP, Jamar F, Ozcan Z, Piciu D, Als C, Franceschi M, Trägårdh E, Zagar I, Sowa-Staszczak A, Cachin F, Bennink R, Forrer F, Adamsen TC, Fotopolous A, Kalnina M, Jensen LT, Mussalo H, Simanek M, Garcia-Cañamaque L, Nazarenko S, Mihailovic J, Bar-Sever Z, O'Connell M, Miladinova D, Graham R, Giubbini R, Kaliská L, Rozić D, Krause BJ, Gallowitsch HJ, Györke T, Sediene S, Rumyantsev P, Wadsak W, Kunikowska J.
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3361-3364.
doi: 10.1007/s00259-021-05484-z . PMID: 34328532 ; PMCID: PMC8322112.

Imaging of Prostate Cancer.
Schlemmer HP, Krause BJ, Schütz V, Bonekamp D, Schwarzenböck S, Hohenfellner M.
Dtsch Arztebl Int. 2021 Oct 22;(Forthcoming):arztebl.m2021.0309.
doi: 10.3238/arztebl.m2021.0309 . Epub ahead of print. PMID: 34427180 .

 

2020

LATE: Nicht jede Demenz ist Alzheimer – Diskussion einer neuen Krankheitsentität am Fallbeispiel : Zum aktuellen Stand der „limbic-predominant age-related TDP-43 encephalopathy“ (LATE) [LATE: not every dementia is Alzheimer's disease-Discussion of a new disease entity based on a case example : Current status of limbic-predominant age-related TDP-43 encephalopathy (LATE)].
Görß D, Kilimann I, Dyrba M, Nitsch S, Krause B, Teipel S.
Nervenarzt. 2020 May 14. German.
doi: 10.1007/s00115-020-00922-z. Epub ahead of print. PMID 32409844.        

The International Radiomics Platform - An Initiative of the German and Austrian Radiological Societies.
Overhoff D, Kohlmann P, Frydrychowicz A, Gatidis S, Loewe C, Moltz J, Kuhnigk JM, Gutberlet M, Winter H, Völker M, Hahn H, Schoenberg SO; Vorstandskommission Radiomics und Big data:; Vorstand der Deutschen Röntgengesellschaft:; Präsidium der Österreichischen Röntgengesellschaft:.
Rofo. 2020 Nov 26. English, German.
doi: 10.1055/a-1244-2775. Epub ahead of print. PMID 33242898.                 

Abnormal Regional and Global Connectivity Measures in Subjective Cognitive Decline Depending on Cerebral Amyloid Status.
Li S, Daamen M, Scheef L, Gaertner FC, Buchert R, Buchmann M, Buerger K, Catak C, Dobisch L, Drzezga A, Ertl-Wagner B, Essler M, Fliessbach K, Haynes JD, Incesoy EI, Kilimann I, Krause BJ, Lange C, Laske C, Priller J, Ramirez A, Reimold M, Rominger A, Roy N, Scheffler K, Maurer A, Schneider A, Spottke A, Spruth EJ, Teipel SJ, Tscheuschler M, Wagner M, Wolfsgruber S, Düzel E, Jessen F, Peters O, Boecker H; DELCODE Study Group.
J Alzheimers Dis. 2020 Dec 10.
doi: 10.3233/JAD-200472. Epub ahead of print. PMID 33337359.                

Semi-automated Analysis of Ventilation-Perfusion Single-Photon Emission Tomography in the Diagnosis of Pulmonary Embolism - Does it add extra value?
Kurth J, Uhländer J, Aladwan H, Göhrendt A, Baier H, Heuschkel M, Schümichen C, Krause BJ, Schwarzenböck SM.
Nuklearmedizin. 2020 Dec;59(6):445-453. English.
doi: 10.1055/a-1253-7951. Epub 2020 Sep 29. PMID 32992376.                                

68 Ga-Labelled Tropane Analogues for the Visualization of the Dopaminergic System.
Häseli S, Holy M, Joksch M, Bergner C, Wree A, Kurth J, Cankaya A, Piel M, Krause BJ, Sitte HH, Rösch F.
ChemMedChem. 2020 Nov 27.
doi: 10.1002/cmdc.202000820. Epub ahead of print. PMID 33245194.              

Cardiomyocyte Transplantation after Myocardial Infarction Alters the Immune Response in the Heart.
Vasudevan P, Wolfien M, Lemcke H, Lang CI, Skorska A, Gaebel R, Koczan D, Lindner T, Engelmann R, Vollmar B, Krause BJ, Wolkenhauer O, Lang H, Steinhoff G, David R.
Cells. 2020 Aug 3;9(8):1825.
doi: 10.3390/cells9081825. PMID 32756334; PMCID: PMC7465503.                

Was passiert eigentlich … in der Hybridbildgebung? [What actually happens … in hybrid imaging?].
Rischpler C, Schlosser T, Umutlu L, Rassaf T, Krause BJ.
Radiologe. 2020 Dec;60(12):1153-1161. German.
doi: 10.1007/s00117-020-00779-y. PMID 33215289.                                     

Anatomical MRI and [18F]FDG-PET/CT imaging of Schistosoma mansoni in a NMRI mouse model
Lindner T, Stenzel J, Koslowski N, Hohn A, Glass Ä, Schwarzenböck SM, Krause BJ, Vollmar B, Reisinger EC, Sombetzki M
Scientific reports 2020;10:17343
doi: 10.1038/s41598-020-74226-2. PMID: 33060721; PMCID: PMC7566647.

Longitudinal [18F]FDG-PET/CT analysis of the glucose netabolism in ApoE-deficient mice
Kuhla A, Meuth L, Stenzel J, Lindner T,Lappe C, Kurth J, Krause BJ, Teipel S, Glass Ä, Kundt G, Vollmar B
EJNMMI 2020;10:119
doi: 10.1186/s13550-020-00711-4. PMID: 33029684; PMCID: PMC7541807.

[68Ga]-NODAGA-RGD Positron Emission Tomography (PET) for Assessment of Post Myocardial Infarction Angiogenesis as a Predictor for Left Ventricular Remodeling in Mice after Cardiac Stem Cell Therapy
Lang CI, Döring P, Gäbel R, Vasaduvean P, Lemcke H, Müller P, Stenzel J, Lindner T, Joksch M, Kurth J, Bergner C, Wester HJ, Ince H, Steinhoff G, Vollmar B, David R, Krause BJ
Cells 2020;30(9):E1358 
doi: 10.3390/cells9061358. PMID: 32486211; PMCID: PMC7349714.

Konsensusempfehlung zur struktuierten Befunderstellung onkologischer PET-Hybridbildgebung
Derlin T, Gatidis S, Krause BJ, Antoch G, Kotzerke J, dos Santos DP, Eiber M, Weber MA, Giesel F, Pfannenberg C, Schlemmer HP, Persigehl T, Herrmann K, Umutlu L
Röfo 2020;192(8):739-744
doi: 10.1055/a-1179-6603. Epub 2020 Jun 16. PMID: 32544953.

Konsensusempfehlung zur struktuierten Befunderstellung onkologischer PET-Hybridbildgebung
Derlin T, Gatidis S, Krause BJ, Antoch G, Kotzerke J, dos Santos DP, Eiber M, Weber MA, Giesel F, Pfannenberg C, Schlemmer HP, Persigehl T, Herrmann K, Umutlu L
Nuklearmedizin 2020;59(4):288-293  
doi: 10.1055/a-1176-0275. Epub 2020 Jun 16. PMID: 32544954.

18-F-FDG PET-based imaging of myocardial inflammation following acute myocardial infarction in a mouse model
Vasudevan P, Gäbel R, Stenzel J, Förster J, Kurth J, Vollmar B, Krause BJ, Ince H, David R, Lang CI
Int J Mol Sci 2020;21(9):3340          
doi: 10.3390/ijms21093340. PMID: 32397287; PMCID: PMC7246846.                 

PSMA-basierte Theranostik beim Prostatakarzinom: Von der Bildgebung zur Therapie
Ilhan H, la Fougére C, Krause BJ
Urologe 2020.59(5);617-625   
doi: 10.1007/s00120-020-01193-x. PMID: 32377764.            

Highlights of the 32th Annual Congress of the EANM, Barcelona 2019: the nucleolympic games of nuclear medicine-a global competition for excellence.
Schwarzenböck SM, Garibotto V.
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1808-1819.
doi: 10.1007/s00259-020-04833-8. Epub 2020 May 15. PMID 32409894.                                 

Coronavirus SARS-CoV-2: Empfehlungen für die nuklearmedizinische Versorgung in nuklearmedizinischen Kliniken/ Abteilungen mit Therapiestation und Praxen, Instituten sowie Ordinationen
Krause BJ
, Bartenstein P, Freudenberg LS, Hermann K, Jonas G, Luster M, Moka D, Schäfer W, Schwarzenböck SM, Meyer PT
Nuklearmedizin 2020;59(2):e1-e4     
doi: 10.1055/a-1147-6722. Epub 2020 Apr 2. PMID: 32241030.                                                             

Perapanel attenuates epilepitform phenotype in C6 glioma
Mayer J, Kirschstein T, Resch T, Porath K, Krause BJ, Köhling R, Lange F
Neurosci Lett 2020;715:134629     
doi: 10.1016/j.neulet.2019.134629. Epub 2019 Nov 14. PMID: 31734290. 

First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer
Kurth J, Krause BJ, Schwarzenböck SM,Bergner C, Hakenberg OW, Heuschkel M
Eur J Nucl med Mol Imaging 2020;47(1):123-135                                              
doi: 10.1007/s00259-019-04504-3. Epub 2019 Sep 3. PMID 31482426.

2019

18F-FDG PET-based imaging of myocardial inflammation predicts a functional outcome following transplantation of mESC-derived cardiac induced cells in a mouse model of myocardial infarction
Vasudevan P, Gaebel R, Doering P, Mueller p, Lemcke H, Stenzel J, Lindner T, Kurth J, Steinhoff G, Vollmar B, Krause BJ, Ince H, David R, Lang CI
Cells 2019;8(12):1613   
doi: 10.3390/cells8121613. PMID: 31835854; PMCID: PMC6952872.

A RadiogenomicApproach for Decoding Molecular Mechanisms Underlying Tumor Progression in Prostate cancer
Fischer S, Tahoun M, Klaan B, Thierfelder KM, Weber MA, Krause BJ, Hakenberg, Fuellen G, Hamed M
Cancers 2019,11:1293  
doi: 10.3390/cancers11091293. PMID: 31480766; PMCID: PMC6770738.                                                                                 

Continuous Blood Sampling in Small Animal Positron Emission Tomography/ Computed Tomography Enables the Measurement of the Arterial Input Function
Mann T, Kurth J, Förster J, Vollmar B, Krause BJ, Wree A, Stenzel J, Lindner T
J Vis Exp 2019;150:e59701   
doi: 10.3791/59701. PMID: 31449263.                                                                         

Whole-body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation
Umutlu L, Beyer T, Grueneisen JS, Rischpler C, Qiuck HH, Veit-Haibach P, Eiber M, Purz S, Antoch G, Gatidis S, Nikolaou K, Schaefer JF, Rausch I, Herrmann K, Vorstand der Interdisziplinären AG für Hybride Bildgebeung in alphabetischer Reihenfolge,Vorstand der Röntgengesellschaft (DRG) und der Dt. Gesellschaft für Nuklearmedizin (DGN) in alphabetischer Reihenfolge
Nuklearmedizin 2019;58(2):68-76         
doi: 10.1055/a-0830-4453. Epub 2019 Feb 28. PMID: 30818412.                                                            

Whole-body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation
Umutlu L, Beyer T, Grueneisen JS, Rischpler C, Qiuck HH, Veit-Haibach P, Eiber M, Purz S, Antoch G, Gatidis S, Nikolaou K, Schaefer JF, Rausch I, Herrmann K, Vorstand der Interdisziplinären AG für Hybride Bildgebeung in alphabetischer Reihenfolge, Vorstand der Röntgengesellschaft (DRG) und der Dt. Gesellschaft für Nuklearmedizin (DGN) in alphabetischer Reihenfolge
RöFo 2019;191(4):289-297   
doi: 10.1055/a-0828-8654. Epub 2019 Feb 28. PMID: 30818411.

[Dopamine Transporter SPECT with I-123 labelled FP-CIT (DaTSCANTM)]
Tatsch K, Buchert R, Bartenstein P, Barthel H, Boecker H, Brust P, Drzezga A, la Fougere C, Gründer G, Grünwald F, Krause BJ, Kuwert T, Langen KJ, Rominger A, Sabri O, Schreckenberger M, Meyer PT
Nuklearmedizin 2019;58:5-16                                                                          
doi: 10.1055/a-0807-8137. Epub 2019 Feb 15. PMID 30769368.

AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro
Lange F, Weßlau K, Porath K, Hörnschemeyer J, Bergner C, Krause BJ, Mullins CS, Linnebacher M, Köhling R, Kirschstein T
PLOS one 2019;14(2):e0211644                                                                      
doi: 10.1371/journal.pone.0211644. PMID 30716120; PMCID: PMC6361447.

FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations
Diehl-Schmid J, Licata A, Goldhardt O, Förstl H, Yakushew I, Otto M, Anerl-Straub S, Beer A, Ludolph AC, Landwehrmeyer GB, Levin J, Danek A, Fliesbach K, Spotke A, Fassbender K, Lyros E, Prudlo J, Krause BJ, Edbauer D, Schroeter ML, Drzezga A, Kornhuber J, Lauer M, FTLDc Study Group, Grimmer T
Transl Psychiatry 2019;9:54    
doi: 10.1038/s41398-019-0381-1. PMID: 30705258; PMCID: PMC6355852.

[18F]-florbetaben PET/CT imaging in the Alzheimer´s disease mouse model APPswe/PS1dE9
Stenzel J, Ruhlmann C, Lindner T, Polei S, Teipel S, Kurth J, Rominger A, Krause BJ, Vollmar B, Kuhla A       
Curr Alzheimer Res 2019;16(1):49-55                                                               
doi: 10.2174/1567205015666181022095904. PMID: 30345916.

2018

Blocking autophagy in cancer-associated fibroblasts supports chemotherapy of pancreatic cancer cells
Zhang X, Schönrogge M, Eichberg J, Wendt EHU, Kumstel S, Stenzel J, Lindner T, Jaster R, Krause BJ, Vollmar B, Zechner D
Front Oncol 2018;8:590 -600    
doi: 10.3389/fonc.2018.00590. PMID: 30568920; PMCID: PMC6290725. 

Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines
Gock M, Mullins CS, Bergner C, Prall F, Ramer R, Göder A, Krämer OH, Lange F, Krause BJ, Klar E, Linnebacher M
World J Gastroenterol 2018;24(43):4880-4892     
doi: 10.3748/wjg.v24.i43.4880. PMID: 30487698; PMCID: PMC6250916.                                            

Nuklearmedizin in Deutschland
Krause BJ

Nuklearmedizin 2018;57(3):66-67       
doi: 10.3413/2018010002. Epub 2018 Jun 5. PMID: 29871007. 

Decitabine demonstrates antileukemic activity in B cell precursor acute lymphoblastic leukemia with MLL rearrangements
Roolf C, Richter A, Konkolefski C, Knuebel G, Sekora A, Krohn S, Stenzel J, Krause BJ, Vollmar B, Murua Escobar H, Lunghanns C        
J Hematol Oncol 2018;11:62        
doi: 10.1186/s13045-018-0607-3. PMID: 29728108; PMCID: PMC5936021.

External radiation exposure, excretion, and effective half-live in 177Lu-PSMA-targeted therapies
Kurth J, Krause BJ, Schwarzenböck SM, Stegger L, Schäfers M, Rahbar K
EJNMMI Res. 2018;8:32    
doi: 10.1186/s13550-018-0386-4. PMID: 29651569; PMCID: PMC5897276.                                                                             

Somatostatin receptor PET/CT (SSTR-PET/CT)
Boy C, Poeppel T, Kotzerke J, Krause BJ, Amthauer H, Baum RP, Buchmann I, Ezziddin S, Führer D, Gabriel M, Kuwert T, Lahner H, Lauenstein T, Maecke HR, Nagarajah J, Rösch F, Scheidhauer K, Schmidt M, Walter MA, Bockisch A
Nuklearmedizin 2018;57(1):4-17
doi: 10.1055/s-0038-1636560. Epub 2018 Feb 21. PMID: 29536494. 

[18F]fallypride-PET/CT Analysis of the Dopamine D₂/D₃ Receptor in the Hemiparkinsonian Rat Brain Following Intrastriatal Botulinum Neurotoxin A Injection.
Mann T, Kurth J, Hawlitschka A, Stenzel J, Lindner T, Polei S, Hohn, A, Krause BJ, Wree A
Molecules 2018;23(3):587      
doi: 10.3390/molecules23030587. PMID: 29509680; PMCID: PMC6017015.                                                                      

Peptide receptor radionuclide therapy with 177Lu-DOTA-octreotate: dosimetry, nephrotoxicity and the effect of hematological toxticity on survival
Löser A, Schwarzenböck SM, Heuschkel M, Willenberg HS, Krause BJ, Kurth J
Nucl Med Commun 2018;39(3):236-246   
doi: 10.1097/MNM.0000000000000795. PMID: 29315138.                                                        

Antifibrogenic effects of vitamin D derivatives on mouse pancreatic stellate cells
Wallbaum P, Rohde S, Lange F, Hohn A, Bergner C, Schwarzenböck SM, Krause BJ, Jaster R
World J Gastroenterol 2018;24(2):170-178     
doi: 10.3748/wjg.v24.i2.170. PMID: 29375203; PMCID: PMC5768936.                                             

[18F] FDG PET/CT for assessing inguinal Lymph nodes in patients with penile cancer – correlation with histopathology after inguinal lymphadenectomy
Dräger DL, Heuschkel M, Protzel Ch, Erbersdobler, Krause BJ, Hakenberg OW, Schwarzenböck SM
Nuklearmedizin 2018;57(1):26-30      
doi: 10.3412/Nukmed-0932-17-10. Epub 2018 Feb 21. PMID: 29536497.

EANM/EARL FDG-PET/CT accreditation – summery results from the first 200 accredited imaging systems
Kaalep A, Sera T, Oyen W, Krause BJ, Chiti A, Liu Y. Boellaard R
Eur J Nucl med Mol Imaging 2018;45(3):412-422 
doi: 10.1007/s00259-017-3853-7. Epub 2017 Dec 1. PMID: 29192365; PMCID: PMC5787222.                                             

EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer
Poeppel TD, Handkiewicz-Junak D, Andreeff M, Becherer A, Bockisch A, Fricke E, Geworski L, Heinzel A, Krause BJ, Krause T, Mitterhauser M, Sonnenschein W, Bodei L, Delcado-Bolton RC, Gabriel M
Eur J Nucl med Mol Imaging 2018;45(5):824-845
doi: 10.1007/s00259-017-3900-4. Epub 2017 Dec 12. PMID: 29234845.

2017

Iterative Learning Control of a Pneumatically Actuated Lung Tumour Mimic Mode
Wache A, Aschemann H, Prabel R, Kurth J, Krause BJ, Zorn S
IFAC-PapersOnLine 2017;50(1):7592-7597

[68Ga]pentixafor for CXCR4 imaging in a PC-3 prostate cancer xenograft model - comparison with [18F]FDG PET/CT, MRI and ex vivo receptor expression
Schwarzenböck SM, Stenzel J, Otto T, Helldorff HV; Bergner C, Kurth J, Polei S, Lindner T, Rauer R, Hohn A, Hakenberg OW, Wester HJ, Vollmar B, Krause BJ
Oncotarget 2017;8(56):95606-95619         
doi: 10.18632/oncotarget.21024. PMID: 29221153; PMCID: PMC5707047.

APPswe/PS1dE9 mice with cortical amyloid pathology show a reduced NAA/Cr ratio without apparent brain atrophy: A MRS and MRI study
Kuhla A, Rühlmann C, Lindner T, Polei S, Hadlich S, Krause BJ, Vollmar B, Teipel SJ
Neuroimage Clin 2017:15;581-586          
doi: 10.1016/j.nicl.2017.06.009. PMID: 28652970; PMCID: PMC5476467. 

Application of in vivo techniques to monitor therapeutic efficiency of PLX4720 in an experimental model of microsatellite instable colorectal cancer
Rohde S, Lindner T, Polei S, Stenzel J, Borufka L, Achilles S, Hartmann E, Lange F, Maletzki C, Linnebacher M, Glass Ä, Schwarzenböck SM, Kurth J, Hohn A, Vollmar B, Krause BJ, Jaster R
Oncotarget 2017;8(41):69756-69767 
doi: 10.18632/oncotarget.19263. PMID: 29050239; PMCID: PMC5642514.

Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatin
Schmid SC, Sathe A, Guerth F, Seitz AK, Heck MM, Maurer T, Schwarzenböck S, Krause BJ, Schulz WA, Stoehr R, Gschwend JE, Retz M, Nawroth R
Urologic Oncology 2017;35(9):544.e1-544.e10  
doi: 10.1016/j.urolonc.2017.04.015. Epub 2017 May 10. PMID: 28501564.                                             

Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions
Fanti S, Minozzi S, Morigi JJ, Giesel F, Ceci F, Uprimny Ch, Hofmann MS, Eiber M, Schwarzenböck S, Castellucci P, Bellisario C, Chauvie St, Bergesio F, Emmett L, Haberkorn U, Virgolini I, Schwaiger M, Hicks RJ, Krause BJ, Chiti A
Eur J Nucl med Mol Imaging 2017;44(10):1622-1635        
doi: 10.1007/s00259-017-3725-1. Epub 2017 May 23. PMID: 28536833.                                

Cardiac cell therapies fort he treatment of acute myocardial infarction: A meta-analysis from mouse studies
Lang CI, Wolfien M, Langenbach A, Müller P, Wolkenhauer O, Yavari A, Ince H, Steinhoff G, Krause BJ, David R, Glass Ä
Cell Physiol Biochem 2017;42:254-268   
doi: 10.1159/000477324. Epub 2017 May 25. PMID: 28535507.         

68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study.
Fendler WP, Calais J, Allen-Auerbach M, Bluemel C, Eberhardt N, Emmett L, Gupta P, Hartenbach M, Hope TA, Okamoto S, Pfob CH, Pöppel TD, Rischpler C, Schwarzenböck S, Stebner V, Unterrainer M, Zacho HD, Maurer T, Gratzke C, Crispin A, Czernin J, Herrmann K, Eiber M.
J Nucl Med. 2017 Oct;58(10):1617-1623.
doi: 10.2967/jnumed.117.190827. Epub 2017 Apr 13. PMID 28408531.                                                

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
Fendler WP, Eiber M, Behesthi M, Bomanji J, Ceci F, Cho St, Giesel F, Haberkorn U, Hope TA, Kopka K, Krause BJ, Mottaghy FM, Schöder H, Sunderland J, Wan S, Wester HJ, Fanti St, Herrmann K
Eur J Nucl Med Mol Imaging 2017;44:1014-1024
doi: 10.1007/s00259-017-3670-z. PMID: 28283702.

German multicenter study investigating 177Lu-PSMA-617 radioligand therapy in advanced prostate cancer patients
Rahbar K, Ahmadzadehfar C, Haberkorn U, Schäfers M, Essler M, Baum RP, Kulkarani HR, Schmidt M, Bartenstein P, Pfestroff A, Lützen U, Marx M, Prasad V, Brenner W, Heinzel A, Ruf J, Meyer PT, Heuschkel M, Eveslage M, Bögemann, M, Fendler WP, Krause BJ
J Nucl Med 2017;58:85-90
doi: 10.2967/jnumed.116.183194. Epub 2016 Oct 20. PMID: 27765862.

Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy.
Eiber M, Fendler WP, Rowe Sp, Calais J, Hofmann M, Maurer T, Schwarzenböck SM, Kratowchil C, Herrmann K, Giesel FL
J Nucl Med 2017;58(Suppl.2):67S-76S 
doi: 10.2967/jnumed.116.186767. PMID: 28864615.

PSMA Ligands for PET-imaging of prostate cancer
Schwarzenböck SM, Raucher I, Bluemel C, Fendler WP, Rowe SP, Pomper MG, Afshar-Oromieh A, Herrmann K, Eiber M
J Nucl M 2017;58(10):1545-1552
doi: 10.2967/jnumed.117.191031. Epub 2017 Jul 7. Erratum in: J Nucl Med. 2017 Nov;58(11):1881. PMID: 28687599.

[11C]Choline PET/CT and whole-body MRI including diffusion-wighted imaging for patients with reccurent prostate cancer
Wieder H, Beer AJ, Holzapfel K, Henninger M, Maurer T, Schwarzenböck SM, Rummeny EJ, Eiber M, Stollfuss J
Oncotarget;2017;8(39):66516-66527
doi: 10.18632/oncotarget.16227. PMID: 29029532; PMCID: PMC5630432.

2016

Nonlinear Tracking Control of a Pneumatically Actuated Lung Tumour Mimic Model
Prabel R, Aschemann H, Kersten J, Schuenemann P, Kurth J, Krause BJ, Jonuchies I
IFAC-PapersOnLine 2016;49:71-76

[11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy
Schwarzenböck SM, Knieling A, Souvatzoglou M, Kurth J, Steiger K, Eiber M, Esposito I, Retz M, Kübler H, Gschwend JE, Schwaiger M, Krause BJ, Thalgott M
Oncotarget 2016;7(39):63747-63757   
doi: 10.18632/oncotarget.11653. PMID: 27572317; PMCID: PMC5325400.

Evaluation of prostate cancer with 11C- and 18F-Choline PET/CT: Diagnosis and initial staging
Nitsch S, Hakenberg OW, Heuschkel M, Dräger D, Hildebrandt G, Krause BJ, Schwarzenböck SM
J Nucl Med 2016;57(Suppl 3):38S-42S     
doi: 10.2967/jnumed.115.169748. PMID: 27694169.

Radionuklidtherapie von Knochenmetastasen mittels Radium-223; S1 Leitlinie
Pöppel, TD, Andreeff M, Becherer A, Bockisch A, Fricke E, Geworski L, Heinzel A, Krause BJ, Mitterhauser M, Scheidhauer K, Schenck M, Sonnenschein W, Gabriel M
Nuklearmedizin 2016;55(5):177-186 

Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate Cancer
Schwarzenböck SM, Eiber M, Kundt G, Retz M, Sakretz M, Kurth J, Treiber U, Nawroth R, Rummeny EJ, Gschwend JE, Schwaiger M, Thalgott M, Krause BJ
Eur J Nucl Med Mol Imaging 2016;43(12):2105-2113   
doi: 10.1007/s00259-016-3439-9. Epub 2016 Jun 17. PMID: 27317482.

The 2015 Revised American Thyreoid Association guidlines for the management of medullary thyreoid carcinoma: the „evidence-based“ refusal to endorse them by EANM due to „not evidence-based“ marginalization of the role of Nuclear Medicine
Treglia G, Aktolun C, Chiti A, Frangos S, Giovanella L, Hoffmann M, Iakovou I, Mihailovic J, Krause BJ, Langsteger W, Verburg FA, Luster M
Eur J Nucl Med Mol Imaging 2016;43:1486-1490    
doi: 10.1007/s00259-016-3404-7. Epub 2016 Apr 27. PMID: 27118126.

Beta-Amyloid-PET-Bildgebung des Gehirns. DGN-Handlungsempfehlung [German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging].
Barthel H, Meyer PT, Drzezga A, Bartenstein P, Boecker H, Brust P, Buchert R, Coenen HH, la Fougére C, Gründer G, Grünwald F, Krause BJ, Kuwert T, Schreckenberger M, Tatsch K, Langen K-J, Sabri O
Nuklearmedizin 2016;55(4):129-137  
doi: 10.3413/Nukmed-0816-16-04. Epub 2016 Apr 15. PMID: 27080914.

Therapie mit 177Lu-PSMA-617 – Dosimetrie und Nachsorge beim metastasierten kastrationsresistenten Prostatakarzinom
Fendler WP, Kratochwill C, Ahmadzadehfar H, Rahbar K, Baum RP, Schmidt M, Pfestroff A, Lützen U, Prasad V, Heizel A, Heuschkel M, Ruf J, Bartenstein P, Krause BJ
Nuklearmedizin 2016;55(3):123-128    
PMID: 27350005.

Increased choline uptake in macrophages and prostate cancer cells does not allow for differentiation between benign and malignant prostate pathologies
Schwarz T, Seidl C, Schiemann M, Senekowitsch-Schmidtke R, Krause BJ
Nuclear Medicine and Biology 2016;43:355-359   
doi: 10.1016/j.nucmedbio.2016.02.004. Epub 2016 Feb 27. PMID: 27260776.

Non-invasive assessment of inter- and intrapatient variability of integrin expression in metastasized prostate cancer by PET
Beer AJ, Schwarzenböck S, Zantl N, Sovatzoglou M, Maurer T, Watzlowik P, Kessler H, Wester HJ, Schwaiger M, Krause BJ
Oncotarget 2016;7(19)28151-9          
doi: 10.18632/oncotarget.8611. PMID: 27058620; PMCID: PMC5053716.

Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasm in Germany: A multi-institutional registry study with prospective follow-up
Hörsch D, Ezzidin S, Haug A, Gratz KF, Dunkelmann S, Miederer M, Schreckenberger M, Krause BJ, Bengel FM, Bartenstein P, Biersack HJ, Pöpperl G, Baum RP
Eur J Cancer 2016;58:41-51 
doi: 10.1016/j.ejca.2016.01.009. Epub 2016 Mar 2. PMID: 26943056.         

18F-fluoroethyl-l-thyrosine (FET) PET to delineate tumor residuals after glioblastoma resection: A comparison to standard postoperative MRI
Buchmann N, Kläsner B, Gempt J, Bauer JS, Pyka T, Delbridge C, Meyer B, Krause BJ, Ringel F
World Neurosurg. 2016;89:420-426 
doi: 10.1016/j.wneu.2016.02.032. Epub 2016 Feb 15. PMID: 26893043.

Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer
Verburg FA, Aktolun C, Chiti A, Frangos S, Giovanella L, Hoffmann M, Iakovou I, Mihailovic J, Krause BJ, Langsteger W, Luster M; EANM and the EANM Thyroid Committee.
Eur J Nucl Med Mol Imaging. 2016;43(6):1001-1005 
doi: 10.1007/s00259-016-3327-3. Epub 2016 Feb 17. PMID: 26883666.

PET/CT with 11 C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta analysis and critical review of available data
Fanti S, Minozzi S, Castellucci P, Balduzzi S, Herrmann K, Krause BJ, Oyen W, Chiti A
Eur J Nucl Med Mol Imaging 2016;43:55-69 
doi: 10.1007/s00259-015-3202-7. Epub 2015 Oct 9. PMID: 26450693.

CDK4/6 Inhibition Controls Proliferation of Bladder Cancer and Transcription of RB1
Sathe A, Koshy N, Schmid SC, Thalgott M, Schwarzenböck SM, Krause BJ, Holm PS, Gschwend JE, Retz M, Nawroth R
J Urol 2016;195:771-779   
doi: 10.1016/j.juro.2015.08.082. Epub 2015 Aug 28. PMID: 26318986.                    

Cardiac FDG-PET: a straight forward tool with high potential
Lang CI, Krause BJ, David R
Eur Heart J Cardiovasc Imaging 2016;17:130-131   
doi: 10.1093/ehjci/jev284. Epub 2015 Oct 28. PMID: 26510929; PMCID: PMC4882887.

Comparison of [11C]Choline ([11C]CHO) and [18F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model
Schwarzenböck SM, Schmeja P, Kurth J, Souvatzoglou M, Nawroth R, Treiber U, Kundt G, Berndt S, Graham K, Senekowitsch-Schmidtke R, Schwaiger M, Ziegler SI, Dinkelborg L, Wester HJ, Krause BJ
Mol Imaging Biol 2016;18(3):393-401
doi: 10.1007/s11307-015-0901-1. PMID: 26483088.

2015

Die Cholin PET/CT für Diagnostik, Staging und Restaging des Prostatakarzinoms
Heuschkel M, Krause BJ, Hakenberg OW, Schwarzenböck SM
Der Nuklearmediziner 2015:38(2):109-118
DOI: 10.1055/s-0035-1549861

The relative importance of imaging markers for the prediction of Alzheimer´s disease in mild cognitive impairmend – Beyond classical regression
Teipel SJ, Kurth J, Krause BJ, Grothe MJ
Neuroimage Clin 2015;8:583-593 
doi: 10.1016/j.nicl.2015.05.006. PMID: 26199870; PMCID: PMC4506984.   

18F-NaF PET/CT: EANM procedure guidlines for bone imaging
Beheshti M, Mottaghy FM, Payche F, Behrendt FFF, Van den Wyngaert T, Fogelmann I, Strobel K, Celli M, Fanti S, Giammarile F, Krause BJ, Langsteger W
Eur J Nucl Med Mol Imaging 2015:42;1767-1777 
doi: 10.1007/s00259-017-3874-2. Erratum for: Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1767-1777. PMID: 29130115.

Early [18F]FET-PET in Gliomas after surgical resection: Comparison with MRI and histopathology
Kläsner B, Buchmann N, Gempt J, Ringel F, Lapa C, Krause BJ
PLOS one 2015:26;10(10):e0141153   
doi: 10.1371/journal.pone.0141153. PMID: 26502297; PMCID: PMC4621037.

124I-PET Assessment of human sodium iodide symporter reporter gene activity for highly sensitive in vivo monitoring of teratoma formation in mice
Lehner S, Lang C, Kaissis G, Todica A, Zacher MJ, Boening G, Spitzweg C, Herbach N, Franz WM, Krause BJ, Steinhoff G, Bartenstein P, Hacker M, David R
Mol Imaging Biol 2015;17(6):874-883  
doi: 10.1007/s11307-015-0857-1. PMID: 25896817.

Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients
Thalgott M, Rack B, Eiber M, Souvatzoglou M, Heck MM, Kronester C, Andergassen U, Kehl V, Krause BJ, Gschwend JE, Retz M, Nawroth R
BMC Cancer 2015;15:458
doi: 10.1186/s12885-015-1478-4. PMID: 26051431; PMCID: PMC4459665.       

Wie schreibe ich eine gute Übersichtsarbeit?
Krause BJ
, Khan C, Antoch G
Nuklearmedizin 2015;54(2):69-74     
doi: 10.3413/Nukmed-2015010002. Epub 2015 Mar 16. PMID: 25774019.

Robust, fully automatic delineation of the head contour by sterotactical normalization for attenuation correction according to Chang in dopamine transporter scintigraphy
Lange C, Kurth J, Seese A, Schwarzenböck S, Steinhoff K, Umland-Seidler B, Krause BJ, Brenner W, Sabri O, Hesse S, Buchert R
Eur Rad 2015 ;25:2709-2717  
doi: 10.1007/s00330-015-3667-6. Epub 2015 Feb 26. PMID: 25716941.

Circulating tumor cells versus objective response assessment predicting survival in metastastic castration-resistant prostate cancer patients trated with docetaxel chmeothyrepy
Thalgott M, Heck MM, Eiber M, Souvatzoglou M, Hatzichristodoulou G, Kehl V, Krause BJ, Rack B, Retz M, Gschwend JE, Andergassen U, Nawroth R
J Cancer Res Clin Oncol 2015;141(8):1457-1464  
doi: 10.1007/s00432-015-1936-z. Epub 2015 Feb 24. PMID: 25708944. 

Peptidrezeptor-Radionuklidtherapie Somatostatinrezeptor-exprimierender Tumore DGN Leitlinie (S1)      
Poeppel TD, Boy C, Kotzerke J, Buchmann I, Ezziddin S, Scheidhauer K, Krause BJ, Schmidt D, Amthauer H, Rösch F, Nagarajah, Führer D, Lahner H, Pöpperl G, Hörsch D, Walter MA, Baum RP
Nuklearmedizin. 2015;54(1):1-11; quiz N2. German.
PMID: 25683107.   

Positronenemissionstomographie 2013 in Deutschland. Ergebnisse der Erhebung und Standortbestimmung [Positron emission tomography 2013 in Germany. Results of the query and current status].
Kotzerke J, Oehme L, Grosse J, Hellwig D, Arbeitausschuss PET der DGN u. a. Krause BJ
Nuklearmedizin 2015;54(2):53-59    
doi: 10.3413/Nukmed-2015020001. Epub 2015 Feb 4. PMID: 25650552.

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.
Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Weber WA, Stroobants S, Delbeke D, Donohoe KJ, Holbrook S, Graham MM, Testanera G, Hoekstra OS, Zijlstra J, Visser E, Hoekstra CJ, Pruim J, Willemsen A, Arends B, Kotzerke J, Bockisch A, Beyer T, Chiti A, Krause BJ.
Eur J Nucl Med Mol Imaging.2015;42(2):328-354   
doi: 10.1007/s00259-014-2961-x. Epub 2014 Dec 2. PMID: 25452219; PMCID: PMC4315529. 

Comparison of [11C]Choline ([11C]CHO) and S(+)-β-Methyl-[11C]Choline ([11C]SMC) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model
Schwarzenböck SM
, Gertz J, Souvatzoglou M, Kurth J, Sachs D, Nawroth R, Treiber U, Schuster T, Senekowitsch-Schmidtke R, Schwaiger M, Ziegler SI, Henriksen G, Wester HJ, Krause BJ
Mol Imaging Biol. 2015;17(2):248-256   
doi: 10.1007/s11307-014-0782-8. PMID: 25163420.

Prediction of Parkinson´s disease subsequent to severe depression: a ten-year follow-up study
Walter U, Heilmann R, Kaulitz L, Just T, Krause BJ, Benecke R, Höppner J
J neural Transm 2015;122(6):789-797 
doi: 10.1007/s00702-014-1313-0. Epub 2014 Sep 14. PMID: 25217967.

Repetitive transcranial magnetic stimulation (rTMS) in schizophrenia with treatment-refractoty auditory hallucinations and major self-mutilation
Schulz T, Berger Ch, Krecklow B, Kurt J, Schwarzenboeck S, Foley P, Thome J, Krause BJ, Hoeppner J
J Neural Transm 2015;122(S1):19-23
doi: 10.1007/s00702-013-1151-5. Epub 2014 Jan 8. PMID: 24398780.

2014

Alzheimer – Frühere Diagnostik dank neuer Bildgebungstechniken
Kurth J
, Kasper E, Teipel S, Krause BJ
DZKF 2014;14-19
https://www.researchgate.net/

CT-based attenuation correction in I-123-Ioflupane SPECT
Lange C, Seese A, Schwarzenböck S, Steinhoff K, Umland-Seidler B, Krause BJ, Brenner W, Sabri O, Kurth J, Hesse S, Buchert R
PLOS one 2014;9(9):e108238     
doi: 10.1371/journal.pone.0108328. PMID: 25268228; PMCID: PMC4182457.   

Welche bildgebenden Verfahren sind in der Demenz-Diagnostik sinnvoll?
Sakretz M, Kurth J, Teipel S, Krause BJ
DNP-Der Neurologe&Psychiater 2014;15(10)
https://www.researchgate.net/

11C-Choline PET/ pathology image coregistration in primary localized prostate cancer
Grosu AL, Weirich G, Wendl C, Prokic V, Kirste S, Geinitz H, Souvatzoglou M, Gschwend JE, Schwaiger M, Molls M, Weber WA, Treiber U, Krause BJ
Eur J Nucl Med Mol Imaging 2014;41(12):2242-2248         
doi: 10.1007/s00259-014-2861-0. Epub 2014 Sep 4. PMID: 25186430.

In-vivo of the acute retention of stem cell derivatives and fribroblasts after intramyocardial transplantation
Lang, C, Lehner S, Todica A, Boening G, Zachert M, Franz WM, Krause BJ, Bartenstein P, Hacker M, David R
Eur J Nucl Med Mol Imaging 2014;41(12):2325-2336  
doi: 10.1007/s00259-014-2858-8. Epub 2014 Jul 26. PMID: 25063040.

Ösophagus- und Magenkarzinom – Staging und Bildgebung
Schwarzenböck S, Krause BJ, Ebert M, Grenacher L
Klinikarzt 2014;43:348-353
https://www.researchgate.net/

Prognostic Value of 11C-Choline PET/CT and CT for Predicting Survival of Bladder Cancer Patients Treated with Radical Cytectomy
Mauerer T, Horn T, Souvatzoglou M, Eiber M, Beer AJ, Heck MM, Haller B, Gschwend JE, Schwaiger M, Treiber U, Krause BJ
Urol Int 2014;93(2):207-213    
doi: 10.1159/000357686. Epub 2014 Jul 9. PMID: 25012094.

Preoperative lymph node Staging in patients with primary prostate cancer: Comparison andcorrelation of quantitative imaging parameters in diffusion weighted imaging [11C]-coline PET/CT
Vag T, Heck M, Beer AJ, Souvatzoglou M, Weirich G, Holzapfel K, Krause BJ, Schwaiger M, Eiber M
Eur Radiol 2014;24(8):1821-1826       
doi: 10.1007/s00330-014-3240-8. Epub 2014 Jun 3. Erratum in: Eur Radiol. 2014 Aug;24(8):1827. PMID: 24889997.             

Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cells
Elsner A, Lange F, Fitzner B, Heuschkel M, Krause BJ, Jaster R
World J of Gastro2014;20(24):7914-7925  
doi: 10.3748/wjg.v20.i24.7914. PMID: 24976727; PMCID: PMC4069318. 

Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C] choline positron emission tomography/ computed tomography for preoperative lymph node staging in prostate cancer patients
Heck M, Souvatzoglou M, Retz M, Nawroth R, Kübler H, Maurer T, Thalgott M, Gramer BM, Weirich G, Rondak IC, Rummeny EJ, Schwaiger M, Gschwend JE, Krause BJ, Eiber M
Eur J Nucl Med Mol Imaging 2014 Apr;41(4):694-701.   
doi: 10.1007/s00259-013-2634-1. Epub 2013 Dec 3. PMID: 24297503.

Cholinergic basal forebrain atrophy predicts amyloidburden in Alzheimer`s disease
Teipel S, Heinsen H, Amaro Jr. E, Grinberg LT, Krause BJ, Grothe M, for the Alzheimer`s Disease Neuroimaging Initiative
Neurobiology of Aging 2014;35:482-491    
doi: 10.1016/j.neurobiolaging.2013.09.029. Epub 2013 Oct 28. PMID: 24176625; PMCID: PMC4120959.

European Association of Nuclear medicine: adapt the present, shape the future
Frangos S, Knapp W, on behalf of the EANM Executive Committee (Krause BJ)
Eur J Nucl Med Mol Imaging 2014;41:590-591   
doi: 10.1007/s00259-013-2676-4. PMID: 24463909.

Quality criteria for multidisciplinary oncology guidelines – the ECCO multidisciplinary clinical guidlines forum
Schrijvers D, van den Velde C, Bregni M, Caraceni A, Cardoso F, Erdem S, Geldenborn H, Grisold W, Honore PGH, Krause BJ, Licitra L, Mansel R, Margilies H, Parsons K, Poston G, Valentini V, Zola P
Eur Assoc Neurooncol Mag 2014;4(1):6-8
https://www.kup.at/journals

Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer
Thalgott M, Horn T, Heck M, Maurer T, Eiber M, Retz M, Autenrieth M, Herkommer K, Krause BJ, Gschwend JE, Treiber U, Kübler HR
J Hematol Oncol. 2014 Mar 5;7:20.   
doi: 10.1186/1756-8722-7-20. PMID: 24598155; PMCID: PMC3974001.

Molekulare multimodale Hybridbildgebung des Prostata- und Blasenkarzinoms
Maurer T, Eiber M, Krause BJ                        
Urologe A. 2014 Apr;53(4):469-83.
doi: 10.1007/s00120-014-3440-5. PMID: 24700188.

Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects
Grothe MJ, Ewers M, Krause B, Heinsen H, Teipel SJ, für the Alzheimer´s Disease Neuroimaging Initiative
Alzheimers Dement. 2014 Oct;10(5 Suppl):S344-53.
doi: 10.1016/j.jalz.2013.09.011. Epub 2014 Jan 10. PMID: 24418052; PMCID: PMC4092050.

Multimodality multiparametric imaging of early tumor response to a novel antiangiogenic therapy based on anticalins.
Meier R, Braren R, Kosanke Y, Bussemer J, Neff F, Wildgruber M, Schwarzenböck S, Frank A, Haller B, Hohlbaum AM, Schwaiger M, Gille H, Rummeny EJ, Beer AJ.
PLoS One. 2014 May 6;9(5):e94972.
doi: 10.1371/journal.pone.0094972. PMID: 24801709; PMCID PMC4011746

2013

Perfusion brain imaging with SPECT-technique. German Guidline S1
Kranert T, Menzel C, Bartenstein P, Brust P, Coenen HH, Krause BJ, Kuwert T, Sabri O, Schreckenberger M, Tatch K, Grünwald F
Nuklearmedizin 2013;52(5):157-162    
PMID: 24085458.

Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates
Krause BJ
, Souvatzoglou M, Treiber U.
Urol Oncol. 2013 May;31(4):427-35.
doi: 10.1016/j.urolonc.2010.08.008. Epub 2011 Mar 8. PMID: 21388835.

Biodistribution and radiation dosimetry in healthy volunteers of a novel tumour-specific probe for PET/CT imaging: BAY 85-8050
Smolarz K, Krause BJ, Graner FP, Wagner FM, Wester HJ, Sell T, Bacher-Stier C, Fels L, Dinkelborg L, Schwaiger M.
Eur J Nucl Med Mol Imaging 2013;40(12):1861-1868
doi: 10.1007/s00259-013-2502-z. Epub 2013 Jul 23. PMID: 23877631.

[11C]choline as a pharmacodynamic marker for docetaxel therapy. Response assessment in a LNCaP prostate cancer xenograft mouse model
Schwarzenböck S, Sachs D, Souvatzoglou M, Schuster T, Nawroth R, Weirich G, Treiber U, Wester HJ, Ziegler S, Schwaiger M, Senekowitsch-Schmidtke R, Krause BJ.
Nuklearmedizin 2013 Aug 8;52(4):141-7 
doi: 10.3413/Nukmed-0521-12-07. Epub 2013 Feb 11. PMID: 23396481.

Molecular imaging of dementia
Kurth J
, Sakretz M, Teipel S, Krause BJ
Geriatric Mental Health Care 2013;1(3):56-62
https://doi.org/10.1016/j.gmhc.2013.04.006

Das Peniskarzinom
Protzel C, Kakies C, Schwarzenböck S, Kuhnt T, Ebersdobler A, Krause BJ, Hakenberg OW
Der Onkologe 2013;19(2):149-162       
DOI: 10.1007/s00761-012-2421-9

Molecular imaging techniques in the diagnosis of dementia
Kurth J
, Kilimann I, Krause BJ, Teipel S
Nervenheilkunde2013;32:725-732     
https://www.researchgate.net/

Tumour volume delineation in prostate cancer assessed by (11C)choline PET/C/: validation with surgical specimens
Bundschuh RA, Wendl CM, Weirich G, Eiber M, Sovatzoglou M, Treiber U, Küberler H, Maurer T, Gschwend JE, Geinitz H, Grosu AL, Ziegler SI, Krause BJ
Eur J Nucl Med Mol Imaging 2013;40(6):824-831   
doi: 10.1007/s00259-013-2345-7. Epub 2013 Feb 7. PMID: 23389430.

Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer
Schwarzenböck S
, Kurth J, Gocke C, Kuhnt T, Hildebrandt G, Krause BJ
Eur J Nucl Med Mol Imaging 2013;40(Suppl 1):28-35  
doi: 10.1007/s00259-013-2404-0. Epub 2013 Apr 11. PMID: 23576101.

(S)-4-(3-18F-Fluoropropyl)-L-Glutamic Acid: An 18F-Labaled Tumor-Specitic Probe for PET/CT Imaging-Dosimetry
Smolarz K, Krause BJ, Graner FP, Wagner FM, Hultsch C, Bacher-Stier C, Sparka RB, Ramsay S, Fels LM, Nunkelborg LM, Schwaiger M
J Nucl Med 2013;54(6):861-866 
doi: 10.2967/jnumed.112.112581. Epub 2013 Apr 8. PMID: 23568366.

2012

S3-guidline-diagnosis and treatment of gastric carcinoma:relevance for radiologic imaging
Grenacher L, Schwarz M, Lordick F, Krause BJ, Roecken C, Moening S, Ebert M, Jenssen C, Kauczor HU, Moehler M, Deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS)
Rofo 2012;184(8):706-12        
doi: 10.1055/s-0031-1299371. Epub 2012 Mar 20. PMID: 22434371.

PET/CT and choline: diagnosis and staging
Farsad M, Schwarzenböck S, Krause BJ
Q J Nucl Med Mol Imaging 2012;56(4):343-53    
PMID: 23013664. 

SNM/EANM Guidline for Guideline Development 6.0
Delbeke D, Chiti A, Christian P, Darcourt J, Donohoe K, Flotats, Krause BJ, Royal HD,
J Nucl Med Technol 2012;40:283-9      
https://tech.snmjournals.org/

18F-FDG PET Detects Inflammatory Infiltrates in Spinal Cord Experimental Autoimmune Encephalomyelitis Lesions
Buck D, Förschler A, Lapa C, Schuster T, Vollmar P, Korn T, Nessler S, Stadelmann C, Drzezga A, Buck AK, Wester HJ, Zimmer C, Hemmer B, Krause BJ
J Nucl Med 2012;53(8):1269-76   
doi: 10.2967/jnumed.111.102608. Epub 2012 Jun 27. PMID: 22738927.

Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy
Maurer T, Souvatzoglou M, Kübler H, Opercan K, Schmidt S, Herrmann K, Stollfuss J, Weirich G, Haller B, Gschwend JE, Schwaiger M, Krause BJ, Treiber U
Eur Urol 2012;61(5):1031-8     
doi: 10.1016/j.eururo.2011.12.009. Epub 2011 Dec 14. PMID: 22196847. 

Choline PET and PET/CT in primary diagnosis and staging of prostate cancer
Schwarzenböck S, Souvatzoglou M, Krause BJ
Theranostics 2012;2(3):318-30   
doi: 10.7150/thno.4008. Epub 2012 Mar 15. PMID: 22448198; PMCID: PMC3311230.

Value of PET/CT ans MR Lymphography in Treatment of Prostate Cancer Patients with Lymph Node Metastases
Fortuin AS, Daserno WMLLG, Meijer HJM, Jager GJ, Takahashi S, Debats OA, Reske SN, Schick C, Krause BJ, van Oort I, Witjes AJ, Hoogeveen YL, van Lin ENJ, Baretsz JO
Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):712-8.
doi: 10.1016/j.ijrobp.2011.12.093. Epub 2012 Mar 13. PMID: 22417806.

2011

Letter to the Editor:
Re: Mottet N, Bellmunt J, Bolla M, et all: EAU Guidelines on Prostate Caner Part II: Treatment of advanced, relapsing and gastration-resistant prostate Caner
Eur Urol 2011;60:e37-e38
https://www.europeanurology.com/article

PET/CT for the diagnosis, staging and restaging of prostatate cancer
Souvatzoglou M, Gärtner F, Schwarzenböck S, Beer AJ, Schwaiger M, Krause BJ
Imaging in Medicine 2011;3(5):571-585   
https://www.openaccessjournals.com/articles/ 

Welche neuen PET-Tracer braucht die Strahlentherapie?
Schwarzenböck S, Herrmann K, Gärtner F, Kläsner B, Souvatzoglou M, Krause BJ
Der Nuklearmediziner 2011;34(2);99-108
https://www.thieme-connect.com/

18F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can do
Herrmann K, Benz MR, Krause BJ, Pomykala KL, Buck AK, Czemin J.
Q J Nucl Med Mol Imaging 2011;55(6):620-32     
PMID: 22231582.

S6K1 and 4E-BP1 are independent regulated and control cellular growth in Bladder cancer
Nawroth R, Stellwagen F, Schulz WA, Stoehr R, Hartmann A, Krause BJ, Gschwend JE, Retz M
PLoS One 2011;6(11):e27509, Epub 2011 Nov 15    
doi: 10.1371/journal.pone.0027509. Epub 2011 Nov 15. PMID: 22110663; PMCID: PMC3216974. 

Prognistic value of (18F)-Flurop-Deoxy-Glucose PET/CT, S100 or MIA for assessment of cancer-associated mortality in patients with high risk melanoma
Essler M, Link A, Belloni B, Mirceva V, Souvatzoglou M, Thaler M, Haller B, Hein R, Krause BJ
PloS One 2011;6(9):e24632, Epub 2011 Sep 14      
doi: 10.1371/journal.pone.0024632. Epub 2011 Sep 14. PMID: 21935432; PMCID: PMC3173468. 

Curative treatment of oesophageal carcinoma: current options and future developments
Wolf MC, Stahl M, Krause BJ, Bonavina C, Bruns C, Belka C, Zehentmayr F
Radiat Oncol 2011;6:55
doi: 10.1186/1748-717X-6-55. PMID: 21615894; PMCID: PMC3127782. 

Molecular imaging of proliferation and glucose utilization: utility for monotoring response and prognosis after neoadjuvant therapy in locally advanced gastric cancer
Ott K, Hermann K, Schuster T, Lange R, Becker K, Wieder HA, Wester HJ, Siewert JR, Büschenfelde CM, Buck AK, Wilhelm D, Ebert MP, Pechel C, Schwaiger M, Lordick F, Krause BJ
Ann Surg Oncol 2011;18(12):3316-23 
doi: 10.1245/s10434-011-1743-y. Epub 2011 May 3. PMID: 21537865.

Positron emission tomography – current role in the diagnostic and treatment of upper gastrointestinal carcinomas
Lordick F, Ott K, Krause BJ             
Dtsch. Med. Wochenschr 2011;136(20):1061-6   
doi: 10.1055/s-0031-1275844. Epub 2011 May 10. PMID: 21560108.

German S3-guidline "Diagnosis and treatment of esophagogastric cancer"
Moehler M, Al-Batran SE, Andus T, Anthuber M, Arends J, Arnold D, Aust D, Baier P, Baretton G, Bernhardt J, Boeing H, Böhle E, Bokemeyer C, Bornschein J, Budach W, Burmester E, Caca K, Diemer WA, Dietrich CF, Ebert M, Eickhoff A, Ell C, Fahlke J, Feussner H, Fietkau R, Fischbach W, Fleig W, Flentje M, Gabbert HE, Galle PR, Geissler M, Gockel I, Graeven U, Grenacher L, Gross S, Hartmann JT, Heike M, Heinemann V, Herbst B, Herrmann T, Höcht S, Hofheinz RD, Höfler H, Höhler T, Hölscher AH, Horneber M, Hübner J, Izbicki JR, Jakobs R, Jenssen C, Kanzler S, Keller M, Kiesslich R, Klautke G, Körber J, Krause BJ, Kuhn C, Kullmann F, Lang H, Link H, Lordick F, Ludwig K, Lutz M, Mahlberg R, Malfertheiner P, Merkel S, Messmann H, Meyer HJ, Mönig S, Piso P, Pistorius S, Porschen R, Rabenstein T, Reichardt P, Ridwelski K, Röcken C, Roetzer I, Rohr P, Schepp W, Schlag PM, Schmid RM, Schmidberger H, Schmiegel WH, Schmoll HJ, Schuch G, Schuhmacher C, Schütte K, Schwenk W, Selgrad M, Sendler A, Seraphin J, Seufferlein T, Stahl M, Stein H, Stoll C, Stuschke M, Tannapfel A, Tholen R, Thuss-Patience P, Treml K, Vanhoefer U, Vieth M, Vogelsang H, Wagner D, Wedding U, Weimann A, Wilke H, Wittekind C; AWMF; AWMF.
Z Gastroenterol. 2011;49(4):461-531    
doi: 10.1055/s-0031-1273201. Epub 2011 Apr 7. PMID: 21476183. 

The sensitivity of [11C]Choline PET/CT to localize prostate cancer depends on the tumor configuration
Souvatzoglou M, Weirich G, Schwarzenboeck S, Maurer T, Schuster T, Bundschuh RA, Eiber M, Herrmann K, Kuebler H, Wester HJ, Hoefler H, Gschwend J, Schwaiger M, Treiber U, Krause BJ
Clin Cancer Res 2011;17(11):3751-9     
doi: 10.1158/1078-0432.CCR-10-2093. Epub 2011 Apr 14. PMID: 21493868.

Influence of [11C]Choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochjemical recurrence of prostate cancer
Souvatzoglou M, Krause BJ, Pürschel A, Thamm R, Schuster T, Buck AK, Zimmermann F, Molis M, Schwaiger M, Geinitz H
Radiother Onco 2011;99(2):193-200         
doi: 10.1016/j.radonc.2011.05.005. Epub 2011 May 26. PMID: 21620494. 

18F-FDG-PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the municon II trial
Meyer zum Büschenfelde C, Herrmann K, Schuster T, Geinitz H, Langer R, Becker K, Ott K, Ebert M, Zimmermann F, Friess H, Schwaiger M, Peschel C, Lordick F, Krause BJ
J Nucl Med 2011;52(8):1189-96   
doi: 10.2967/jnumed.110.085803. Epub 2011 Jul 15. PMID: 21764790.

German Guidelines for brain-tumor imaging by PET ans SPECT using labeled amino acids
Langen KJ, Bartenstein P, Boecker H, Brust P, Coenen HH, Drzezga A, Grünwald F, Krause BJ, Kuwert T, Sabri O, Tatsch K, Weber WA, Schreckenberger M
Nuklearmedizin 2011;50(4):167-73     
doi: 10.3413/nuk-2011041. Epub 2011 Jul 14. PMID: 21789338.

Radionuclide and Hybrid Imaging of Recurrent Prostate Cancer
Beer A, Eiber M, Souvatzoglou M, Schwaiger M, Krause BJ
Lancet Oncology 2011;12(2):181-91
doi: 10.1016/S1470-2045(10)70103-0. Epub 2010 Jul 6. PMID: 20599424. 

The Role of choline positron emission tomography/computed tomography in the management of patients with prostatate-spcific antigen progression after radical treatment of prostate cancer
Picchio M, Briganti A ,Fanti S, Heidenreich A, Krause BJ, Messa C, Montorsi F, Reske SN, Thalmann GN         
Eur Urology 2011;59(1):51-60  
doi: 10.1016/j.eururo.2010.09.004. Epub 2010 Sep 15. PMID: 20869161. 

Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in 11C-Choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer
Beer AJ, Eiber M, Souvatzoglou M, Holzapfel K, Ganter C, Weirich G, Maurer T, Kübler H, Wester HJ, Gaa J, Krause BJ
Mol Imag Biol  2011;13(2):352-61
doi: 10.1007/s11307-010-0337-6. PMID: 20490932.

Comparison of different SUV-based methods for prediction of response to neoadjuvant radiochemotherapy in locally advanced rectal cancer by FDG-PET and MRI
Herrmann K, Bundschuh RA, Rosenberg R, Schmidt S, Praus C, Souvatzoglou M, Becker K, Schuster T, Essler M, Wieder HA, Friess H, Ziegler SI, Schwaiger M, Krause BJ
Mol Imag Biol 2011;13(5):1011-9
doi: 10.1007/s11307-010-0383-0. PMID: 20936364.